ليتروزول تيڤع

Country: ইস্রায়েল

ভাষা: আরবী

সূত্র: Ministry of Health

সক্রিয় উপাদান:

LETROZOLE 2.5 MG

থেকে পাওয়া:

TEVA PHARMACEUTICAL INDUST.LTD

এটিসি কোড:

L02BG04

ফার্মাসিউটিকাল ফর্ম:

TABLETS

প্রশাসন রুট:

PER OS

Manufactured by:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Therapeutic group:

LETROZOLE

থেরাপিউটিক ইঙ্গিত:

Letrozole teva tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: Letrozole teva is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

অনুমোদন তারিখ:

2010-01-01